176 related articles for article (PubMed ID: 24721883)
1. Treatment of recalcitrant erythrodermic psoriasis with ustekinumab.
Stinco G; Piccirillo A; Errichetti E; Bergamo S; Patrone P
Eur J Dermatol; 2014; 24(3):387-90. PubMed ID: 24721883
[No Abstract] [Full Text] [Related]
2. Erythrodermic psoriasis treated with ustekinumab: an Italian multicenter retrospective analysis.
Pescitelli L; Dini V; Gisondi P; Loconsole F; Piaserico S; Piccirillo A; Stinco G; Errichetti E; Talamonti M; Tripo L; Volpi W; Prignano F
J Dermatol Sci; 2015 May; 78(2):149-51. PubMed ID: 25681953
[No Abstract] [Full Text] [Related]
3. Ustekinumab in severe complicated erythrodermic psoriasis: rapid clearing, safety, and sustained remission.
Koutsoukou XA; Papadavid E; Theodoropoulos K; Rigopoulos D
Dermatol Ther; 2014; 27(5):257-9. PubMed ID: 24813816
[TBL] [Abstract][Full Text] [Related]
4. Life-threatening pustular and erythrodermic psoriasis responding to infliximab.
Lewis TG; Tuchinda C; Lim HW; Wong HK
J Drugs Dermatol; 2006 Jun; 5(6):546-8. PubMed ID: 16774108
[TBL] [Abstract][Full Text] [Related]
5. Erythrodermic psoriasis improved by panitumumab, but not bevacizumab.
Nishizawa A; Satoh T; Yokozeki H
Acta Derm Venereol; 2012 Jul; 92(4):360-1. PubMed ID: 22565356
[No Abstract] [Full Text] [Related]
6. Erythrodermic, recalcitrant psoriasis: clinical resolution with infliximab.
Rongioletti F; Borenstein M; Kirsner R; Kerdel F
J Dermatolog Treat; 2003 Dec; 14(4):222-5. PubMed ID: 14660268
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of ustekinumab in sub-erythrodermic psoriasis: when TNF-blockers fail.
Buggiani G; D'Erme AM; Krysenka A; Pescitelli L; Lotti T; Prignano F
Dermatol Ther; 2012; 25(3):283-5. PubMed ID: 22913449
[No Abstract] [Full Text] [Related]
8. Erythrodermic psoriasis.
Mumoli N; Vitale J; Gambaccini L; Sabatini S; Brondi B; Cei M
QJM; 2014 Apr; 107(4):315. PubMed ID: 23764512
[No Abstract] [Full Text] [Related]
9. [Treatment of erythrodermic psoriasis with cyclosporin].
Manganoni AM; Giustina A; Zuccato F; Calzavara P; Pasolini G; Braga D; Gavazzoni R
G Ital Dermatol Venereol; 1988 Dec; 123(12):675-6. PubMed ID: 2978160
[No Abstract] [Full Text] [Related]
10. Treatment of erythrodermic psoriasis with biologics: A systematic review.
Carrasquillo OY; Pabón-Cartagena G; Falto-Aizpurua LA; Santiago-Vázquez M; Cancel-Artau KJ; Arias-Berrios G; Martín-García RF
J Am Acad Dermatol; 2020 Jul; 83(1):151-158. PubMed ID: 32247872
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience of ixekizumab in the treatment of patients with history of chronic erythrodermic psoriasis who failed secukinumab: a case series.
Lo Y; Tsai TF
Br J Dermatol; 2019 Nov; 181(5):1106-1107. PubMed ID: 31145806
[No Abstract] [Full Text] [Related]
12. Sustained efficacy of ustekinumab in refractory erythrodermic psoriasis after failure of antitumor necrosis factor therapies.
Castiñeiras I; Fernández-Diaz L; Juárez Y; Lueiro M
J Dermatol; 2012 Aug; 39(8):730-1. PubMed ID: 22364316
[No Abstract] [Full Text] [Related]
13. Use of short-course class 1 topical glucocorticoid under occlusion for the rapid control of erythrodermic psoriasis.
Arbiser JL; Grossman K; Kaye E; Arndt KA
Arch Dermatol; 1994 Jun; 130(6):704-6. PubMed ID: 8002640
[No Abstract] [Full Text] [Related]
14. Psoriasis-induced postoperative cardiac failure.
Jha PK; Das SR; Musleh GS; Lakshmanan S; Kingston TP; Deiraniya AK
Ann Thorac Surg; 2005 Apr; 79(4):1390-1. PubMed ID: 15797087
[TBL] [Abstract][Full Text] [Related]
15. Humanized monoclonal anti-CD25 antibody as a novel therapeutic option in HIV-associated psoriatic erythroderma.
Dichmann S; Mrowietz U; Schöpf E; Norgauer J
J Am Acad Dermatol; 2002 Oct; 47(4):635-6. PubMed ID: 12271320
[No Abstract] [Full Text] [Related]
16. Successful Secukinumab treatment of generalized pustular psoriasis and erythrodermic psoriasis.
Mugheddu C; Atzori L; Lappi A; Pau M; Murgia S; Rongioletti F
J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):e420-e421. PubMed ID: 28319281
[No Abstract] [Full Text] [Related]
17. Infliximab (Remicade) for acute, severe pustular and erythrodermic psoriasis.
Lisby S; Gniadecki R
Acta Derm Venereol; 2004; 84(3):247-8. PubMed ID: 15202853
[No Abstract] [Full Text] [Related]
18. Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation.
Rosenbach M; Hsu S; Korman NJ; Lebwohl MG; Young M; Bebo BF; Van Voorhees AS;
J Am Acad Dermatol; 2010 Apr; 62(4):655-62. PubMed ID: 19665821
[TBL] [Abstract][Full Text] [Related]
19. Infliximab combined with methotrexate as long-term treatment for erythrodermic psoriasis.
Heikkilä H; Ranki A; Cajanus S; Karvonen SL
Arch Dermatol; 2005 Dec; 141(12):1607-10. PubMed ID: 16365275
[No Abstract] [Full Text] [Related]
20. Erythroderma in the era of biological therapies.
Zattra E; Belloni Fortina A; Peserico A; Alaibac M
Eur J Dermatol; 2012; 22(2):167-71. PubMed ID: 22321651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
